Abbott Laboratories (ABT) EBITDA Margin Growth (5y) (2014 - 2026)
Abbott Laboratories (ABT) EBITDA Margin Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.38 Bn | 18.97 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -17.00 |
| Mar 31, 2026 | -812.00 |
| Dec 31, 2025 | -308.00 |
| Sep 30, 2025 | 121.00 |
| Jun 30, 2025 | 925.00 |
| Mar 31, 2025 | 653.00 |
| Dec 31, 2024 | 71.00 |
| Sep 30, 2024 | 265.00 |
| Jun 30, 2024 | 97.00 |
| Mar 31, 2024 | 410.00 |
| Dec 31, 2023 | 238.00 |
| Sep 30, 2023 | 324.00 |
| Jun 30, 2023 | 410.00 |
| Mar 31, 2023 | 725.00 |
| Dec 31, 2022 | 434.00 |
| Sep 30, 2022 | 574.00 |
| Jun 30, 2022 | 1,529.00 |
| Mar 31, 2022 | 2,830.00 |
| Dec 31, 2021 | 594.00 |
| Sep 30, 2021 | 638.00 |